169 related articles for article (PubMed ID: 727903)
21. A double-blind trial of phenelzine and amitriptyline in depressed out-patients. A possible differential effect of the drugs on symptoms.
Kay DW; Garside RF; Fahy TJ
Br J Psychiatry; 1973 Jul; 123(572):63-7. PubMed ID: 4580991
[No Abstract] [Full Text] [Related]
22. [The comparative studies of therapeutic results in patients with psychotic refractory depression treated with selected antidepressants and unilateral ECT].
Hese RT; Gruszczyński W; Szwed A; Kielc M; Zalitacz M
Psychiatr Pol; 2002; 36(6 Suppl):81-4. PubMed ID: 12647425
[TBL] [Abstract][Full Text] [Related]
23. Responses to phenelzine and amitriptyline absence of differential predictors by multiple regression analysis.
Bhat AV; Rowan PR; Paykel ES
J Affect Disord; 1984 Apr; 6(2):209-18. PubMed ID: 6233353
[TBL] [Abstract][Full Text] [Related]
24. Amitriptyline, nortriptyline plasma levels and clinical response in women with affective disorders.
Corona GL; Pinelli P; Zerbi F; Fenoglio L; Santagostino G; Frattini P; Cucchi ML
Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):102-10. PubMed ID: 7393996
[TBL] [Abstract][Full Text] [Related]
25. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.
Robinson DS; Nies A; Ravaris CL; Lamborn KR
Arch Gen Psychiatry; 1973 Sep; 29(3):407-13. PubMed ID: 4579506
[No Abstract] [Full Text] [Related]
26. Plasma levels of catecholamines and dihydroxyphenylglycol during antidepressant drug treatment.
Robinson DS; Johnson GA; Nies A; Corcella J; Cooper TB; Albright D; Howard D
J Clin Psychopharmacol; 1983 Oct; 3(5):282-7. PubMed ID: 6355207
[TBL] [Abstract][Full Text] [Related]
27. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression.
Davidson J; McLeod MN; Blum MR
Am J Psychiatry; 1978 Apr; 135(4):467-9. PubMed ID: 345825
[TBL] [Abstract][Full Text] [Related]
28. THE ANTIDEPRESSANT DRUGS.
HORDERN A
N Engl J Med; 1965 Jun; 272():1159-69. PubMed ID: 14284986
[No Abstract] [Full Text] [Related]
29. Response to phenelzine and amitriptyline in subtypes of outpatient depression.
Paykel ES; Rowan PR; Parker RR; Bhat AV
Arch Gen Psychiatry; 1982 Sep; 39(9):1041-9. PubMed ID: 7052009
[TBL] [Abstract][Full Text] [Related]
30. Electroconvulsive therapy and antidepressant drugs in manic-depressive disease. Treatment results at discharge and 3 months later.
Bratfos O; Haug JO
Acta Psychiatr Scand; 1965; 41(4):588-96. PubMed ID: 5884008
[No Abstract] [Full Text] [Related]
31. Combined antidepressant therapy.
Winston F
Br J Psychiatry; 1971 Mar; 118(544):301-4. PubMed ID: 5575932
[No Abstract] [Full Text] [Related]
32. Correspondence: The management of resistant depression.
Shaw DM; Hewland R
Br J Psychiatry; 1973 Oct; 123(575):489-90. PubMed ID: 4748866
[No Abstract] [Full Text] [Related]
33. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
[TBL] [Abstract][Full Text] [Related]
34. Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment.
Murphy DL; Brand E; Goldman T; Baker M; Wright C; van Kammen D; Gordon E
J Nerv Ment Dis; 1977 Feb; 164(2):129-34. PubMed ID: 836485
[TBL] [Abstract][Full Text] [Related]
35. Triiodothyronine potentiation of the antidepressant effect of phenelzine.
Joffe RT
J Clin Psychiatry; 1988 Oct; 49(10):409-10. PubMed ID: 3170493
[TBL] [Abstract][Full Text] [Related]
36. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study.
Navarro V; Gastó C; Torres X; Masana G; Penadés R; Guarch J; Vázquez M; Serra M; Pujol N; Pintor L; Catalán R
Am J Geriatr Psychiatry; 2008 Jun; 16(6):498-505. PubMed ID: 18515694
[TBL] [Abstract][Full Text] [Related]
37. Effects of phenelzine and amitriptyline on depression [proceedings].
Paykel ES; Rowan PR; Parker RR
Psychopharmacol Bull; 1981 Jan; 17(1):104-6. PubMed ID: 7232635
[No Abstract] [Full Text] [Related]
38. Effects of tricyclic antidepressants on platelet monoamine oxidase activity.
Reyes E; Lisansky J
Clin Pharmacol Ther; 1984 Apr; 35(4):531-4. PubMed ID: 6705452
[TBL] [Abstract][Full Text] [Related]
39. Response of psychotic and nonpsychotic depression to phenelzine.
Janicak PG; Pandey GN; Davis JM; Boshes R; Bresnahan D; Sharma R
Am J Psychiatry; 1988 Jan; 145(1):93-5. PubMed ID: 3337297
[TBL] [Abstract][Full Text] [Related]
40. In vivo inhibition of platelet MAO activity by tricyclic antidepressants.
Sullivan JL; Dackis C; Stanfield C
Am J Psychiatry; 1977 Feb; 134(2):188-90. PubMed ID: 835743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
